🇺🇸 FDA
Pipeline program

ILT-101 liquide, Placebo of ILT-101, CICLOSPORIN

P120142

Phase 2 small_molecule active

Quick answer

ILT-101 liquide, Placebo of ILT-101, CICLOSPORIN for Patient with newly diagnosed (≤ 3 months) type 1 diabetes stage 3 is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Patient with newly diagnosed (≤ 3 months) type 1 diabetes stage 3
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials